
| air-lift bioreactor, ahnak, agropine | |
| akaryotic, al+, alamethicin |
| Systematic (IUPAC) name | |
|---|---|
| (17R,21β)-ajmalan- 17,21-diol OR (1R,9R,10S,13R,14R,16S,18S)- 13-ethyl- 8-methyl- 8,15-diazahexacyclo [14.2.1.01,9.02,7.010,15.012,17] nonadeca- 2(7),3,5-triene- 14,18-diol |
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 4360-12-7 |
| ATC code | C01BA05 |
| PubChem | CID 20367 |
| DrugBank | DB01426 |
| ChemSpider | 10469368 |
| UNII | 1PON08459R |
| KEGG | D00199 |
| ChEMBL | CHEMBL1230919 |
| Chemical data | |
| Formula | C20H26N2O2 |
| Mol. mass | 326.433 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Ajmaline is an alkaloid that is class Ia antiarrhythmic agent. It is often used to bring out typical findings of ST elevations in patients suspected of having Brugada syndrome.
The compound was first isolated by Salimuzzaman Siddiqui in 1931 [1] from the roots of Rauwolfia serpentina. He named it ajmaline, after Hakim Ajmal Khan, one of the most illustrious practitioners of Unani medicine in South Asia.[2]
|
||||||||||||||||||||||||||||||||||||||||||||||||
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)